Published Date: 26 Apr 2023
Nearly a quarter of the body's sugar energy, or glucose, is consumed daily by the human brain, which also has a sweet tooth. Now, scientists from the Gladstone Institutes and UC San Francisco (UCSF) have provided fresh insight into how.
Read Full NewsBy analyzing data from three clinical trials treating children with the brain tumor medulloblastoma, scientists at St. Jude Children's Research Hospital have designed an approach to safely reduce therapy, thereby lowering ...
Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a study shows.
People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the average survival time for patients diagnosed in 2011, according to a major study of patient data in ...
1.
Are ultramarathon runners really at increased risk of bowel cancer?
2.
Breast cancer: A new target to eliminate dormant cells before they wake
3.
Clinical trial: Patients with locally advanced, muscle-invasive bladder cancer do not benefit from extended lymph node removal.
4.
Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.
5.
Treatment of Oligometastatic EGFR-Mutant Lung Cancer
1.
Exploring the Mystery of Angiokeratomas on Scrotum: Causes, Symptoms and Treatment
2.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
3.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
4.
The Ultimate Guide to Understanding Abiraterone and its Uses in Cancer Treatment
5.
Understanding Drug-Induced Cardiotoxicity: Mechanisms, Impact, and Future Directions
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
2.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation